• Modena launches phase I trial of its COVID-19 vaccine candidate, mRNA-1273. Source
• France institutes a two-week lockdown,n, which extends to 11 May.
• Modena launches phase I trial of its COVID-19 vaccine candidate, mRNA-1273. Source
• France institutes a two-week lockdown,n, which extends to 11 May.